Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan J Feld

Showing results (171-180 of 395) with videos related to

Pageof 40
Sort By:
Viruses|June 2, 2021
Evaluation of Dried Blood Spot Testing for SARS-CoV-2 Serology Using a Quantitative Commercial AssayDavor Brinc, Mia J Biondi, Daniel Li, et al.
Journal of Viral Hepatitis|September 4, 2025
Early Read-Time Performance of the OraQuick HCV Rapid Antibody Assay for the Exclusion of HCV ViremiaJessie Torgersen, David Smookler, Rebecca Russell, et al.
Digestive Diseases and Sciences|April 6, 2023
Low Rate of Hepatitis B Reactivation Among Patients with Chronic Hepatitis C During Direct Acting Antiviral TherapyNehna Abdul Majeed, Ahmad Samer Alawad, Kin Seng Liem, et al.
Drug and Alcohol Review|July 13, 2023
Increasing linkage to hepatitis C care following trauma-informed rehabilitation: An education and quality improvement project among womenAgustina Crespi, Rafique Van Uum, Helen Lathouris, et al.
The Journal of Clinical Psychiatry|August 2, 2023
Evaluation of Hepatitis C Screening and Treatment Among Psychiatry InpatientsErin Mandel, Mia J Biondi, Andrew Mendlowitz, et al.
Frontiers in Immunology|October 25, 2021
Determinants of Ligand Specificity and Functional Plasticity in Type I Interferon SignalingDuncan Kirby, Baljyot Parmar, Sepehr Fathi, et al.
The Lancet. Gastroenterology & Hepatology|February 15, 2020
Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the badMarc G Ghany, Jordan J Feld, Kyong-Mi Chang, et al.
Journal of Viral Hepatitis|November 25, 2021
The impact of the first, second and third waves of covid-19 on hepatitis B and C testing in Ontario, CanadaErin Mandel, Adriana Peci, Kirby Cronin, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patientsBirgit Edlich, Golo Ahlenstiel, Aintzane Zabaleta Azpiroz, et al.
Gut|May 3, 2015
The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infectionMahmoud Abu-Amara, Orlando Cerocchi, Gurtej Malhi, et al.
Pageof 40

Showing results (171-180 of 395) with videos related to

Sort By:
Pageof 40
Viruses|June 2, 2021
Evaluation of Dried Blood Spot Testing for SARS-CoV-2 Serology Using a Quantitative Commercial AssayDavor Brinc, Mia J Biondi, Daniel Li, et al.
Journal of Viral Hepatitis|September 4, 2025
Early Read-Time Performance of the OraQuick HCV Rapid Antibody Assay for the Exclusion of HCV ViremiaJessie Torgersen, David Smookler, Rebecca Russell, et al.
Digestive Diseases and Sciences|April 6, 2023
Low Rate of Hepatitis B Reactivation Among Patients with Chronic Hepatitis C During Direct Acting Antiviral TherapyNehna Abdul Majeed, Ahmad Samer Alawad, Kin Seng Liem, et al.
Drug and Alcohol Review|July 13, 2023
Increasing linkage to hepatitis C care following trauma-informed rehabilitation: An education and quality improvement project among womenAgustina Crespi, Rafique Van Uum, Helen Lathouris, et al.
The Journal of Clinical Psychiatry|August 2, 2023
Evaluation of Hepatitis C Screening and Treatment Among Psychiatry InpatientsErin Mandel, Mia J Biondi, Andrew Mendlowitz, et al.
Frontiers in Immunology|October 25, 2021
Determinants of Ligand Specificity and Functional Plasticity in Type I Interferon SignalingDuncan Kirby, Baljyot Parmar, Sepehr Fathi, et al.
The Lancet. Gastroenterology & Hepatology|February 15, 2020
Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the badMarc G Ghany, Jordan J Feld, Kyong-Mi Chang, et al.
Journal of Viral Hepatitis|November 25, 2021
The impact of the first, second and third waves of covid-19 on hepatitis B and C testing in Ontario, CanadaErin Mandel, Adriana Peci, Kirby Cronin, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patientsBirgit Edlich, Golo Ahlenstiel, Aintzane Zabaleta Azpiroz, et al.
Gut|May 3, 2015
The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infectionMahmoud Abu-Amara, Orlando Cerocchi, Gurtej Malhi, et al.
Pageof 40